| mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0061 |
0.8 |
| mRNA |
A-804598 |
CTRPv2 |
pan-cancer |
AAC |
0.0083 |
0.9 |
| mRNA |
lapatinib |
CCLE |
pan-cancer |
AAC |
-0.008 |
0.9 |
| mRNA |
Imatinib |
CTRPv2 |
pan-cancer |
AAC |
0.0065 |
0.9 |
| mRNA |
XMD11-85h |
GDSC1000 |
pan-cancer |
AAC |
-0.0091 |
0.9 |
| mRNA |
HLI 373 |
CTRPv2 |
pan-cancer |
AAC |
-0.0064 |
0.9 |
| mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.022 |
0.9 |
| mRNA |
NVP-ADW742 |
CTRPv2 |
pan-cancer |
AAC |
0.0062 |
0.9 |
| mRNA |
AS605240 |
GDSC1000 |
pan-cancer |
AAC |
-0.0061 |
0.9 |
| mRNA |
OSI-930 |
GDSC1000 |
pan-cancer |
AAC |
0.0063 |
0.9 |